Antimicrobial Agents Practice Questions

Q: All of the following are risk factors for renal toxicity caused by aminoglycosides EXCEPT:

Simultaneous use of penicillin. ***Simultaneous use of penicillin*** - Penicillins are **not considered a major risk factor** for aminoglycoside nephrotoxicity. - While aminoglycosides and penicillins can be inactivated when mixed **in vitro** (in IV solutions), this does not translate to a protective effect against renal toxicity **in vivo**. - The major nephrotoxic drug combinations with aminoglycosides include **vancomycin, amphotericin B, cyclosporine, NSAIDs, and loop diuretics** - not penicillins. *Hypokalemia* - **Electrolyte imbalances**, such as hypokalemia, can worsen renal function and increase the susceptibility of the kidneys to damage from nephrotoxic drugs like aminoglycosides. - **Volume depletion** and electrolyte disturbances are common comorbidities that exacerbate aminoglycoside-induced acute kidney injury. *Aminoglycoside administration in recent past* - Prior exposure to aminoglycosides, especially within a short period, can lead to **cumulative toxicity** due to incomplete renal recovery from previous dosing. - The kidneys require time to regenerate epithelial cells damaged by aminoglycosides, and repeated exposure increases the risk of **irreversible damage**. *Elderly patient* - **Age** is a significant risk factor because elderly patients often have **decreased renal blood flow** and a reduced number of functional nephrons. - The **glomerular filtration rate (GFR)** naturally declines with age, making the kidneys more vulnerable to drug-induced injury.

Q: What is the treatment of choice for Campylobacter infections?

Erythromycin. Erythromycin - **Erythromycin**, a macrolide antibiotic, is the **correct answer among the given options** for *Campylobacter* infections. - It works by inhibiting bacterial protein synthesis at the 50S ribosomal subunit, effectively reducing the duration and severity of symptoms in acute gastroenteritis. - **Modern practice note:** While azithromycin (another macrolide) has largely replaced erythromycin as the **preferred first-line agent** due to better tolerability, once-daily dosing, and fewer GI side effects, erythromycin remains effective and is the best choice listed here [1]. - Macrolides are particularly indicated in severe cases with high fever, bloody diarrhea, or in immunocompromised patients. *Tetracycline* - While tetracyclines have broad-spectrum activity, they are **not first-line treatment** for *Campylobacter* due to increasing resistance rates globally [2]. - Resistance mechanisms include efflux pumps and ribosomal protection proteins. - May still have some role in regions with documented susceptibility, but macrolides are preferred. *Ampicillin* - **Ampicillin** and other beta-lactam antibiotics are **ineffective** against *Campylobacter* species. - *Campylobacter* possesses intrinsic resistance to beta-lactams through beta-lactamase production and altered penicillin-binding proteins. - Cell wall synthesis inhibitors are therefore not useful for this infection. *Ciprofloxacin* - **Ciprofloxacin** and other fluoroquinolones were previously common first-line agents but are **no longer recommended** due to widespread resistance. - Resistance rates exceed 50-90% in many countries, particularly linked to fluoroquinolone use in poultry farming. - Should only be used if susceptibility testing confirms sensitivity, which is rarely practical in acute gastroenteritis.

Q: Drug of choice for rheumatic fever prophylaxis in a penicillin-allergic patient is?

Erythromycin. ***Erythromycin*** - **Erythromycin** is the **recommended alternative** for **rheumatic fever prophylaxis** in patients with **penicillin allergy** according to **American Heart Association (AHA) guidelines**. - Typical regimen: **Erythromycin estolate 250 mg BID** or **erythromycin ethylsuccinate 400 mg BID**. - Effective against **Streptococcus pyogenes** (Group A Streptococcus), the causative organism of acute rheumatic fever. - While macrolide resistance exists in some regions, erythromycin remains the **guideline-recommended choice** when penicillin cannot be used. *Clindamycin* - **Clindamycin** is **not recommended** by major guidelines (AHA, WHO) for routine rheumatic fever prophylaxis. - Lacks adequate evidence and official guideline support for this specific indication. - May be considered in specific cases but is not the standard alternative. *Vancomycin* - **Vancomycin** is reserved for **multidrug-resistant infections** such as **MRSA**. - Not indicated for rheumatic fever prophylaxis due to high cost, need for IV administration, and potential for resistance development. - Reserved for life-threatening infections where other options have failed. *Gentamycin* - **Gentamycin** is an **aminoglycoside** used primarily for **severe gram-negative infections**. - Lacks adequate activity against **Streptococcus pyogenes**. - Not appropriate for rheumatic fever prophylaxis.

Q: All of the following bind to the 50S ribosomal unit except:

Tetracycline. ***Tetracycline*** - **Tetracyclines** bind to the **30S ribosomal subunit**, specifically inhibiting protein synthesis by blocking the binding of aminoacyl-tRNA to the A-site. - This mechanism is distinct from the other listed antibiotics which target the 50S subunit. *Macrolide* - **Macrolide antibiotics** bind to the **50S ribosomal subunit** to inhibit bacterial protein synthesis by blocking translocation and peptidyl transferase activity. - This binding prevents the ribosome from moving along the mRNA, effectively halting protein elongation. *Lincosamide* - **Lincosamides**, such as clindamycin, also bind to the **50S ribosomal subunit** at a site overlapping with macrolides and chloramphenicol. - They inhibit protein synthesis by hindering peptidyl transferase and stalling chain elongation. *Chloramphenicol* - **Chloramphenicol** binds to the **50S ribosomal subunit** and inhibits protein synthesis by blocking the peptidyl transferase activity. - This prevents the formation of peptide bonds between amino acids, thereby stopping protein chain elongation.

Question 1

All of the following are risk factors for renal toxicity caused by aminoglycosides EXCEPT:

Accepted Answer

Simultaneous use of penicillin

Answer

Hypokalemia

Answer

Aminoglycoside administration in recent past

Answer

Elderly patient

Question 2

All of the following are true about rifabutin except which of the following?

Accepted Answer

It is more effective for newly diagnosed TB as compared to Rifampicin

Answer

It has lesser incidence of drug interactions as compared to Rifampicin

Answer

It is more effective against MAC as compared to Rifampicin

Answer

It has longer half life than Rifampicin

Question 3

What is the treatment of choice for Campylobacter infections?

Accepted Answer

Erythromycin

Answer

Tetracycline

Answer

Ampicillin

Answer

Ciprofloxacin

Question 4

Drug of choice for rheumatic fever prophylaxis in a penicillin-allergic patient is?

Accepted Answer

Erythromycin

Answer

Vancomycin

Answer

Gentamycin

Answer

Clindamycin

Question 5

All of the following bind to the 50S ribosomal unit except:

Accepted Answer

Tetracycline

Answer

Macrolide

Answer

Lincosamide

Answer

Chloramphenicol

Question 6

Which specific beta-lactamase inhibitor is commonly used to enhance the efficacy of beta-lactam antibiotics in the treatment of bacterial endocarditis?

Accepted Answer

Tazobactam

Answer

Clavulanic acid

Answer

Sulbactam

Answer

Avibactam

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?